⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Thomas ChanMD

Pulmonary Disease · New York, NY 10013

NPI: 1548333552

Share:

3

🟢 Low

Risk Flags

High fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

20,921

Total Claims

$3.5M

Drug Cost

864

Beneficiaries

$4,062

Cost/Patient

Risk Score Breakdown 3/100

Low (0)Moderate (15)Elevated (30)High (50+)
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 9,082 Pulmonary Disease providers

-21%

Cost per patient vs peers

$4,062 vs $5,138 avg

-41%

Brand preference vs peers

36.1% vs 61.4% avg

Brand vs Generic

64% generic

Brand: 7,538 claims · $3.2M

Generic: 13,366 claims · $359K

Patient Profile

76

Avg Age

43%

Female

1.63

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About